---
title: "301130.SZ (301130.SZ) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/301130.SZ/news.md"
symbol: "301130.SZ"
name: "301130.SZ"
parent: "https://longbridge.com/zh-CN/quote/301130.SZ.md"
datetime: "2026-03-10T10:33:50.950Z"
locales:
  - [en](https://longbridge.com/en/quote/301130.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301130.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301130.SZ/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/301130.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301130.SZ/news.md)


# 301130.SZ (301130.SZ) — 相关新闻

### [XDYY: Cumulative share repurchase reached 1.0001% of total share capital](https://longbridge.com/zh-CN/news/277899230.md)
*2026-03-05T07:58:17.000Z*
> XDYY announced that as of March 5, 2026, the company has repurchased a total of 765,000 shares through a dedicated secur

### [XDYY plans to spend between 25 million and 50 million yuan to implement a share repurchase](https://longbridge.com/zh-CN/news/273355871.md)
*2026-01-22T10:17:03.000Z*
> XDYY announced that the company plans to repurchase shares to implement an employee stock ownership plan or equity incen

### [The head of the Department of Consumption Promotion of the Ministry of Commerce interprets the "Opinions on Promoting the High-Quality Development of the Pharmaceutical Retail Industry"](https://longbridge.com/zh-CN/news/273353757.md)
*2026-01-22T10:03:37.000Z*
> The "Opinions" propose 9 key measures in 5 areas aimed at promoting the high-quality development of the pharmaceutical r

### [XDYY: Glucosamine Sulfate Capsules have obtained the drug registration certificate](https://longbridge.com/zh-CN/news/273349203.md)
*2026-01-22T09:26:03.000Z*
> XDYY recently obtained the drug registration certificate for Glucosamine Sulfate Capsules issued by the National Medical

### [XDYY released its performance for the first three quarters, with a net profit attributable to the parent company of 33.1464 million yuan, a decrease of 2.7%](https://longbridge.com/zh-CN/news/262841212.md)
*2025-10-27T08:22:04.000Z*
> XDYY released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 189 mi

### [XDYY: Obtained an invention patent certificate](https://longbridge.com/zh-CN/news/261828918.md)
*2025-10-20T07:45:31.000Z*
> XDYY announced that the company recently obtained an invention patent certificate issued by the National Intellectual Pr

### [XDYY: Shares of shareholders holding more than 5% have been judicially frozen](https://longbridge.com/zh-CN/news/261233698.md)
*2025-10-15T10:52:40.000Z*
> XDYY announced that the shares held by its shareholder Hengqin Dingdian Equity Investment Fund Partnership (Limited Part

### [In the first half of the year, XDYY's non-net profit increased by 12.26% year-on-year, with sales revenue of key products growing](https://longbridge.com/zh-CN/news/253014827.md)
*2025-08-14T10:15:39.000Z*
> XDYY (301130) disclosed its semi-annual report for 2025 on August 14, during the reporting period, the company achieved 

### [XDYY: Net profit of 24.9446 million yuan in the first half of 2025, a year-on-year increase of 2.02%](https://longbridge.com/zh-CN/news/252986433.md)
*2025-08-14T07:58:37.000Z*
> XDYY announced that its operating income in the first half of 2025 was 128 million yuan, a year-on-year decrease of 0.51